SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: David Howe who wrote (7601)12/23/2002 4:15:24 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Dave,

Genelabs is the most involved with lupus. LJPC also has some trials involving kidney problems in lupus. Finally I recall CAT/HGSI doing something with lupus.

Peter



To: David Howe who wrote (7601)12/23/2002 4:27:36 PM
From: keokalani'nui  Read Replies (2) | Respond to of 52153
 
David:

You could scroll up through this. Except for CTLA4-Ig, Biomaven has named the more advanced programs. (I am not sure alxn's eculizumab is on the thread, but it is a possibility where there is kidney involvement.)

Message 15433773

I haven't kept the thread up, so keep looking. And please contribute if you get a moment.

W


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News